274 related articles for article (PubMed ID: 27404978)
41. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.
Marchaim D; Chopra T; Bhargava A; Bogan C; Dhar S; Hayakawa K; Pogue JM; Bheemreddy S; Blunden C; Shango M; Swan J; Lephart PR; Perez F; Bonomo RA; Kaye KS
Infect Control Hosp Epidemiol; 2012 Aug; 33(8):817-30. PubMed ID: 22759550
[TBL] [Abstract][Full Text] [Related]
42. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
43. "Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.
Marchaim D; Perez F; Lee J; Bheemreddy S; Hujer AM; Rudin S; Hayakawa K; Lephart PR; Blunden C; Shango M; Campbell ML; Varkey J; Manickam P; Patel D; Pogue JM; Chopra T; Martin ET; Dhar S; Bonomo RA; Kaye KS
Am J Infect Control; 2012 Nov; 40(9):830-5. PubMed ID: 22325727
[TBL] [Abstract][Full Text] [Related]
44. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
[TBL] [Abstract][Full Text] [Related]
45. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa.
Cotton MF; Wasserman E; Smit J; Whitelaw A; Zar HJ
BMC Infect Dis; 2008 Apr; 8():40. PubMed ID: 18380900
[TBL] [Abstract][Full Text] [Related]
46. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Hyle EP; Ferraro MJ; Silver M; Lee H; Hooper DC
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1242-9. PubMed ID: 21029005
[TBL] [Abstract][Full Text] [Related]
47. Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes.
Chong YP; Choi SH; Kim ES; Song EH; Lee EJ; Park KH; Cho OH; Kim SH; Lee SO; Kim MN; Jeong JY; Woo JH; Kim YS
Diagn Microbiol Infect Dis; 2010 May; 67(1):70-7. PubMed ID: 20227228
[TBL] [Abstract][Full Text] [Related]
48. Asymptomatic colonization with carbapenem resistant enterobacteriaceae (CRE) in ICU patients and its associated risk factors: Study from North India.
Datta P; Gupta V; Singla N; Chander J
Indian J Med Microbiol; 2015; 33(4):612-3. PubMed ID: 26470985
[No Abstract] [Full Text] [Related]
49. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
50. Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment.
Miller BM; Johnson SW
Am J Infect Control; 2016 Feb; 44(2):134-7. PubMed ID: 26492818
[TBL] [Abstract][Full Text] [Related]
51. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
52. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
[TBL] [Abstract][Full Text] [Related]
53. Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.
Nabarro LE; Veeraraghavan B
Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2307-11. PubMed ID: 26363636
[TBL] [Abstract][Full Text] [Related]
54. Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.
Chaubey VP; Pitout JD; Dalton B; Gregson DB; Ross T; Laupland KB
BMC Infect Dis; 2014 Dec; 14():647. PubMed ID: 25494640
[TBL] [Abstract][Full Text] [Related]
55. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.
van Duin D; Kaye KS; Neuner EA; Bonomo RA
Diagn Microbiol Infect Dis; 2013 Feb; 75(2):115-20. PubMed ID: 23290507
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
Vlieghe ER; Huang TD; Phe T; Bogaerts P; Berhin C; De Smet B; Peetermans WE; Jacobs JA; Glupczynski Y
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1223-9. PubMed ID: 25717021
[TBL] [Abstract][Full Text] [Related]
57. Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-β-lactamases?
Yan JJ; Lee NY; Chen HM; Wang MC; Ko WC; Tsai LH; Wu JJ
Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):345-52. PubMed ID: 23001510
[TBL] [Abstract][Full Text] [Related]
58. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Shah PG; Shah SR
J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
[TBL] [Abstract][Full Text] [Related]
59. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.
Brink A; Coetzee J; Clay C; Corcoran C; van Greune J; Deetlefs JD; Nutt L; Feldman C; Richards G; Nordmann P; Poirel L
S Afr Med J; 2012 May; 102(7):599-601. PubMed ID: 22748433
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
